Join to view full profile
300 Pasteur DrDepartment of PathologyStanford, CA 94305
Phone+1 650-723-4000
Dr. Tai is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lisa Tai is a pathologist in South San Francisco, CA and is affiliated with Lucile Packard Children's Hospital Stanford. She received her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 23 years. She specializes in cytopathology, hematopathology, anatomic pathology, and clinical pathology. She has 16 publications and over 50 citings.
Education & Training
University of California (San Francisco) School of MedicineFellowship, Cytology Fellowship / Clinical Instructorship, 1999 - 2000- University of California (San Francisco)Fellowship, Hematopathology, 1998 - 1999
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1997 - 1998- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1994 - 1997
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2028
IN State Medical License 2013 - 2021
VA State Medical License 2002 - 2016
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancers.Wei Zhou, Musaddeque Ahmed, Jane Guan, Natalie S Fox, Jason Oeh
Cell Chemical Biology. 2026-06-18 - Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response.Amanda R Moore, Brian Biehs, Noelyn Kljavin, Thi Thu Thao Nguyen, Akansha Shah
Nature Genetics. 2026-06-01 - 17 citationsGiredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao, Bu-Er Wang, Lisa Tai
Science Translational Medicine. 2022-09-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
